BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9057590)

  • 1. p53: functions, mutations and sarcomas.
    Hung J; Anderson R
    Acta Orthop Scand Suppl; 1997 Feb; 273():68-73. PubMed ID: 9057590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
    Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
    Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas.
    Wadayama B; Toguchida J; Yamaguchi T; Sasaki MS; Yamamuro T
    Br J Cancer; 1993 Dec; 68(6):1134-9. PubMed ID: 8260365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 in bone and soft tissue sarcomas.
    Thoenen E; Curl A; Iwakuma T
    Pharmacol Ther; 2019 Oct; 202():149-164. PubMed ID: 31276706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 gene mutations and p53 protein expression in human soft tissue sarcomas.
    Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI
    Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted mutation of p53 and Rb in mesenchymal cells of the limb bud produces sarcomas in mice.
    Lin PP; Pandey MK; Jin F; Raymond AK; Akiyama H; Lozano G
    Carcinogenesis; 2009 Oct; 30(10):1789-95. PubMed ID: 19635748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma.
    Toguchida J; Yamaguchi T; Dayton SH; Beauchamp RL; Herrera GE; Ishizaki K; Yamamuro T; Meyers PA; Little JB; Sasaki MS
    N Engl J Med; 1992 May; 326(20):1301-8. PubMed ID: 1565143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas.
    Toguchida J; Yamaguchi T; Ritchie B; Beauchamp RL; Dayton SH; Herrera GE; Yamamuro T; Kotoura Y; Sasaki MS; Little JB
    Cancer Res; 1992 Nov; 52(22):6194-9. PubMed ID: 1423262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
    Malkin D; Li FP; Strong LC; Fraumeni JF; Nelson CE; Kim DH; Kassel J; Gryka MA; Bischoff FZ; Tainsky MA
    Science; 1990 Nov; 250(4985):1233-8. PubMed ID: 1978757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas.
    Cordon-Cardo C; Latres E; Drobnjak M; Oliva MR; Pollack D; Woodruff JM; Marechal V; Chen J; Brennan MF; Levine AJ
    Cancer Res; 1994 Feb; 54(3):794-9. PubMed ID: 8306343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two germ-line mutations affecting the same nucleotide at codon 257 of p53 gene, a rare site for mutations.
    Mazoyer S; Lalle P; Moyret-Lalle C; Marçais C; Schraub S; Frappaz D; Sobol H; Ozturk M
    Oncogene; 1994 Apr; 9(4):1237-9. PubMed ID: 8134127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis.
    Ito M; Barys L; O'Reilly T; Young S; Gorbatcheva B; Monahan J; Zumstein-Mecker S; Choong PF; Dickinson I; Crowe P; Hemmings C; Desai J; Thomas DM; Lisztwan J
    Clin Cancer Res; 2011 Feb; 17(3):416-26. PubMed ID: 21159888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soft tissue sarcoma metastasis from clonal expansion of p53 mutated tumor cells.
    Pollock RE; Lang A; Luo J; El-Naggar AK; Yu D
    Oncogene; 1996 May; 12(9):2035-9. PubMed ID: 8649865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
    Stratton MR; Moss S; Warren W; Patterson H; Clark J; Fisher C; Fletcher CD; Ball A; Thomas M; Gusterson BA
    Oncogene; 1990 Sep; 5(9):1297-301. PubMed ID: 2216456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
    Frebourg T; Kassel J; Lam KT; Gryka MA; Barbier N; Andersen TI; Børresen AL; Friend SH
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6413-7. PubMed ID: 1631137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 transgenic mice are highly susceptible to 1, 2-dimethylhydrazine-induced uterine sarcomas.
    Zhang Z; Li J; Lantry LE; Wang Y; Wiseman RW; Lubet RA; You M
    Cancer Res; 2002 Jun; 62(11):3024-9. PubMed ID: 12036908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas.
    Wunder JS; Czitrom AA; Kandel R; Andrulis IL
    J Natl Cancer Inst; 1991 Feb; 83(3):194-200. PubMed ID: 1988704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 Mutation and MDM2 amplification in human soft tissue sarcomas.
    Leach FS; Tokino T; Meltzer P; Burrell M; Oliner JD; Smith S; Hill DE; Sidransky D; Kinzler KW; Vogelstein B
    Cancer Res; 1993 May; 53(10 Suppl):2231-4. PubMed ID: 8387391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer risks from germ line tumor suppressor gene mutations.
    Frebourg T; Malkin D; Friend S
    Princess Takamatsu Symp; 1991; 22():61-70. PubMed ID: 1844252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas.
    Latres E; Drobnjak M; Pollack D; Oliva MR; Ramos M; Karpeh M; Woodruff JM; Cordon-Cardo C
    Am J Pathol; 1994 Aug; 145(2):345-55. PubMed ID: 8053493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.